Search
Patexia Research
Case number 2024-1936

Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC > Documents

Date Field Doc. No.Description (Pages)
Sep 6, 2024 62 AMICUS CURIAE BRIEF FILED by Federal Trade Commission. Service: 09/06/2024 by email. (PENDING COMPLIANCE REVIEW) [1030661] [24-1936] [Anupama Sawkar] [Entered: 09/06/2024 04:03 PM] (42)
Sep 6, 2024 61 Entry of Appearance for Anupama Sawkar; Matthew Michael Hoffman; Bradley Vettraino; Jordan T. Klimek as counsel for Federal Trade Commission. Service: 09/06/2024 by email. [1030656] [24-1936] [Anupama Sawkar] [Entered: 09/06/2024 03:52 PM] (2)
Sep 6, 2024 60 AMICUS CURIAE BRIEF FILED by 14 Professors of Medicine and Law as Amicus Curiae in Support of Defendants-Appellees. Service: 09/06/2024 by email. (PENDING COMPLIANCE REVIEW) [1030611] [24-1936] [Kristen Johnson] [Entered: 09/06/2024 02:34 PM] (45)
Sep 6, 2024 59 Certificate of Interest for 14 Professors of Medicine and Law as Amicus Curiae In Support of Defendants-Appellees. Service: 09/06/2024 by email. [1030544] [24-1936] [Kristen Johnson] [Entered: 09/06/2024 01:07 PM] (6)
Sep 6, 2024 58 Entry of Appearance for Kristen A. Johnson; Lauriane Williams as counsel for 14 Professors of Medicine and Law as Amicus Curiae In Support of Defendants-Appellees. Service: 09/06/2024 by email. [1030541] [24-1936] [Kristen Johnson] [Entered: 09/06/2024 01:05 PM] (3)
Sep 6, 2024 57 CORRECTED AMICUS CURIAE BRIEF FILED by Amicus Curiae Deva Holding A.S.. Service: 09/06/2024 by email. (PENDING COMPLIANCE REVIEW) [1030518] [24-1936] [Shashank Upadhye] [Entered: 09/06/2024 11:45 AM] (38)
Sep 6, 2024 56 Corrected Entry of Appearance for SHASHANK UPADHYE; YIXIN TANG; BRENT BATZER as counsel for AMICUS CURIAE DEVA HOLDING A.S.. Service: 09/06/2024 by email. [1030517] [24-1936] [Shashank Upadhye] [Entered: 09/06/2024 11:41 AM] (2)
Sep 5, 2024 55 AMICUS CURIAE BRIEF FILED by Sandoz Inc.. Service: 09/05/2024 by email. (PENDING COMPLIANCE REVIEW) [1030447] [24-1936] [Laura Lydigsen] [Entered: 09/05/2024 11:13 PM] (24)
Sep 5, 2024 54 Certificate of Interest for Sandoz Inc.. Service: 09/05/2024 by email. [1030446] [24-1936] [Laura Lydigsen] [Entered: 09/05/2024 11:10 PM] (2)
Sep 5, 2024 53 Entry of Appearance for Laura A. Lydigsen; Mark H. Remus; Mary E. LaFleur as counsel for Sandoz Inc.. Service: 09/05/2024 by email. [1030445] [24-1936] [Laura Lydigsen] [Entered: 09/05/2024 11:08 PM] (2)
Sep 4, 2024 52 NOTICE OF NON-COMPLIANCE: The submission of Amicus Curiae Deva Holding A.S., Amicus Curiae Brief, Entry of Appearance [50], [47], is not in compliance with the rules of this court (see attached). Compliant document due on 09/11/2024. Service as of this date by the Clerk of Court. [1029928] [JSP] [Entered: 09/04/2024 03:21 PM] (2)
Sep 4, 2024 51 NOTICE OF NON-COMPLIANCE: The submission of Amici Curiae Margo Bagley, Jeremy Bock, Michael A. Carrier, Michael W. Carroll, Prof. Bernard Chao, Thomas Cheng, Colleen Chien, Andrew Chin, Ralph Clifford, Jorge Contreras, Stacey L. Dogan, Charles Duan, Stacie Dusetzina, Brian L. Frye, Bronwyn Hall, Paul J. Heald, Yaniv Heled, Cynthia Ho, Tim Holbrook, Erik Hovenkamp, Herbert Hovenkamp, Robert Lande, Stacey Lantagne, Mark A. Lemley, Christopher R. Leslie, Prof. Yvette Joy Liebesman, Lee Ann Wheelis Lockridge, Brian Love, Duncan Matthews, Roger Noll, Tyler T. Ochoa, David Olson, Luigi Palombi, Jordan Paradise, Menesh Patel, Stephanie Plamondon, Srividhya Ragavan, Arti K. Rai, Daniel L. Rubinfeld, Ana Santos Rutschman, William Sage, Christopher L. Sagers, Joshua D. Sarnoff, Ameet Sarpatwari, Steven Semeraro, Jake Sherkow, Michael Sinha, David Stein, Jennifer Sturiale, Madhavi Sunder, Liza Vertinsky and Melissa Wassermann, Entry of Appearance, Amicus Curiae Brief [46], is not in compliance with the rules of this court (see attached). Compliant document due on 09/11/2024. Service as of this date by the Clerk of Court. [1029883]--[Edited 09/04/2024 by JSP to include Entry of Appearance] [JSP] [Entered: 09/04/2024 01:49 PM] (2)
Sep 3, 2024 50 AMICUS CURIAE BRIEF FILED by AMICUS CURIAE DEVA HOLDING A.S. represented by SHASHANK UPADHYE. Service: 09/03/2024 by email. [1029535] [24-1936] This document is non-compliant. See Doc No.[52] [Shashank Upadhye] [Entered: 09/03/2024 03:39 PM] (38)
Sep 3, 2024 49 Certificate of Interest for Deva Holding A.S.. Service: 09/03/2024 by email. [1029530] [24-1936] [Shashank Upadhye] [Entered: 09/03/2024 03:36 PM] (3)
Sep 3, 2024 48 Notice of Related Case Information for Deva Holding A.S.. Service: 09/03/2024 by email. [1029529] [24-1936] [Shashank Upadhye] [Entered: 09/03/2024 03:35 PM] (2)
Sep 3, 2024 47 Entry of Appearance for Shashank Upadhye; Yixin Tang; Brent Batzer as counsel for DEVA HOLDING A.S.. Service: 09/03/2024 by email. [1029526] [24-1936] This document is non-compliant. See Doc No.[52] [Shashank Upadhye] [Entered: 09/03/2024 03:33 PM] (2)
Aug 30, 2024 46 AMICUS CURIAE BRIEF FILED by 52 Professors of Law, Economics, and Medicine as Amici Curiae. Service: 08/30/2024 by email. [1029326] [24-1936] This document is non-compliant. See Doc No.[51] [Mark Lemley] [Entered: 08/30/2024 06:32 PM] (35)
Aug 30, 2024 45 Certificate of Interest for 52 Professors of Law, Economics, and Medicine as Amici Curiae. Service: 08/30/2024 by email. [1029324] [24-1936] [Mark Lemley] [Entered: 08/30/2024 05:50 PM] (8)
Aug 30, 2024 44 Entry of Appearance for Professor Mark A. Lemley; Professor Michael A. Carrier as counsel for 52 Professors of Law, Economics, and Medicine as Amici Curiae. Service: 08/30/2024 by email. This document is non-compliant. See Doc No. [46] [1029323] [24-1936] [Mark Lemley] [Entered: 08/30/2024 05:47 PM] (6)
Aug 30, 2024 43 MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Amneal Ireland Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC and Amneal Pharmaceuticals, Inc.. Service: 08/30/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1029281] --[Edited 09/04/2024 by JSP - compliance review complete] [Steven Maddox] [Entered: 08/30/2024 04:06 PM] (67)
Aug 7, 2024 42 MODIFIED ENTRY: AMICUS BRIEF FILED by Sanofi-Aventis U.S. LLC. Service: 08/07/2024 by email. [1023409]--[Edited 08/08/2024 by JSP - compliance review complete] [Robert Stander] [Entered: 08/07/2024 01:40 PM] (37)
Aug 7, 2024 41 NOTICE OF NON-COMPLIANCE: The submission of Amicus Curiae Sanofi-Aventis U.S. LLC, Amicus Brief [37], is not in compliance with the rules of this court (see attached). Compliant document due on 08/14/2024. Service as of this date by the Clerk of Court. [1023353] [JSP] [Entered: 08/07/2024 11:23 AM] (2)
Aug 6, 2024 40 MODIFIED ENTRY: AMICUS BRIEF FILED by AstraZeneca Pharmaceuticals LP. Service: 08/06/2024 by email. [1023245]--[Edited 08/07/2024 by JSP - compliance review complete] [Christopher Sipes] [Entered: 08/06/2024 07:54 PM] (27)
Aug 6, 2024 39 Certificate of Interest for Amicus Curiae AstraZeneca Pharmaceuticals LP. Service: 08/06/2024 by email. [1023244] [24-1936] [Christopher Sipes] [Entered: 08/06/2024 07:51 PM] (3)
Aug 6, 2024 38 Entry of Appearance for Christopher N. Sipes; R. Jason Fowler; Michael K. Stern as counsel for Amicus Curiae AstraZeneca Pharmaceuticals LP. Service: 08/06/2024 by email. [1023243] [24-1936] [Christopher Sipes] [Entered: 08/06/2024 07:48 PM] (2)
Aug 6, 2024 37 AMICUS CURIAE BRIEF FILED by Sanofi-Aventis U.S. LLC. Service: 08/06/2024 by email. [1023205] [24-1936] This document is non-compliant. See Doc No.[41] [Robert Stander] [Entered: 08/06/2024 04:23 PM] (37)
Aug 6, 2024 36 Certificate of Interest for Amicus Curiae Sanofi-Aventis U.S. LLC. Service: 08/06/2024 by email. [1023203] [24-1936] [Robert Stander] [Entered: 08/06/2024 04:19 PM] (3)
Aug 6, 2024 35 Entry of Appearance for Robert N. Stander as counsel for Amicus Curiae Sanofi-Aventis U.S. LLC. Service: 08/06/2024 by email. [1023202] [24-1936] [Robert Stander] [Entered: 08/06/2024 04:15 PM] (1)
Jul 30, 2024 34 MODIFIED ENTRY OPENING BRIEF FILED by Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 07/30/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1021634] --[Edited 08/05/2024 by JSP - compliance review complete] [William Jay] [Entered: 07/30/2024 06:44 PM] (234)
Jul 24, 2024 33 Entry of Appearance for Thomas V. McTigue IV; Louis L. Lobel as counsel for Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 07/24/2024 by email. [1020408] [24-1936] [Thomas McTigue] [Entered: 07/24/2024 05:12 PM] (2)
Jul 10, 2024 32 ORDER The motion for stay pending appeal under Rule 8/18 [12] is granted to the extent that the district court's June 10, 2024 order is stayed until further notice of this court. The Clerk of Court shall transmit a copy of this order to the merits panel assigned to this appeal. (Per Curiam). Service as of this date by the Clerk of Court. [1016712] [NL] [Entered: 07/10/2024 01:40 PM] (2)
Jul 3, 2024 31 Confidential Appellants' Reply in Support of Their Motion for a Stay Pending Appeal filed by Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc. corresponding to Doc. No. [30]. Service: 07/03/2024 by email. [1015360] [24-1936] [William Jay] [Entered: 07/03/2024 12:31 PM] (0)
Jul 3, 2024 30 REPLY of Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc. to response [27]. Service: 07/03/2024 by email. [1015356] [24-1936] [William Jay] [Entered: 07/03/2024 12:23 PM] (19)
Jul 1, 2024 29 ORDER The motion to expedite the appeal [5] is granted to the following extent: the opening brief is due no later than July 30, 2024. The response brief is due no later than August 30, 2024, and the reply brief and joint appendix are due no later than September 11, 2024. The appeal shall be placed on the November 2024 oral argument calendar. No extensions of time will be granted. (Per Curiam). Service as of this date by the Clerk of Court. [1014563] [NL] [Entered: 07/01/2024 01:06 PM] (2)
Jun 28, 2024 28 Confidential Appellees' Opposition to Plaintiffs' Motion to Stay Pending Appeal filed by Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Amneal Ireland Ltd. corresponding to Doc. No. [27]. Service: 06/28/2024 by email. [1014256] [24-1936] [Steven Maddox] [Entered: 06/28/2024 12:52 PM] (0)
Jun 28, 2024 27 RESPONSE of Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Amneal Ireland Ltd. to Doc No. [12]. Service: 06/28/2024 by email. [1014254] [24-1936] [Steven Maddox] [Entered: 06/28/2024 12:50 PM] (31)
Jun 28, 2024 26 ORDER Appellees' response to the motion to stay [12] is due no later than June 28, 2024. Appellants' reply in support of the motion is due no later than 2:00 p.m. Eastern time on Wednesday, July 3, 2024. (Per Curiam). Service as of this date by the Clerk of Court. [1014219] [NL] [Entered: 06/28/2024 11:03 AM] (2)
Jun 27, 2024 25 Confidential Appellants' Reply in Support of Their Motion to Expedite filed by Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc. corresponding to Doc. No. [24]. Service: 06/27/2024 by email. [1014058] [24-1936] [William Jay] [Entered: 06/27/2024 03:50 PM] (0)
Jun 27, 2024 24 REPLY of Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc. to response [17]. Service: 06/27/2024 by email. [1014053] [24-1936] [William Jay] [Entered: 06/27/2024 03:43 PM] (13)
Jun 27, 2024 23 ORDER The motion [21] to seal ECF No. [16] is granted. ECF No. [16] is sealed, and access to it shall be restricted in accordance with Federal Circuit Rule 25.1. Service as of this date by the Clerk of Court. [1014023] [NL] [Entered: 06/27/2024 03:03 PM] (2)
Jun 26, 2024 22 Docketing Statement for the Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 06/26/2014 by email. [1013530] [24-1936] [William Jay] [Entered: 06/26/2024 09:43 AM] (2)
Jun 25, 2024 21 MOTION of Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Amneal Ireland Ltd. to seal document No. [16]. Service: 06/25/2024 by email. [1013381] [24-1936] [Steven Maddox] [Entered: 06/25/2024 03:14 PM] (8)
Jun 25, 2024 20 Docketing Statement for the Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Amneal Ireland Ltd.. Service: 06/25/2024 by email. [1013230] [24-1936] [Steven Maddox] [Entered: 06/25/2024 11:12 AM] (2)
Jun 25, 2024 19 Confidential Appellees' Partial Opposition to Motion to Expedite filed by Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Amneal Ireland Ltd. corresponding to Doc. No. [17]. Service: 06/25/2024 by email. [1013187] [24-1936] [Steven Maddox] [Entered: 06/25/2024 10:29 AM] (0)
Jun 25, 2024 18 NOTICE OF NON-COMPLIANCE: The submission of Appellees Amneal Ireland Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC and Amneal Pharmaceuticals, Inc., Confidential Response [16], is not in compliance with the rules of this court (see attached). Compliant document due on 07/02/2024. Service as of this date by the Clerk of Court. [1013180] [JSP] [Entered: 06/25/2024 10:22 AM] (2)
Jun 25, 2024 17 RESPONSE of Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Amneal Ireland Ltd. to Doc No. [5]. Service: 06/25/2024 by email. [1013153] [24-1936] [Steven Maddox] [Entered: 06/25/2024 09:56 AM] (16)
Jun 25, 2024 16 RESPONSE of Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Amneal Ireland Ltd. to Doc No. [5]. Service: 06/25/2024 by email. [1013152] [24-1936] This document is non-compliant. See Doc No.[18] [Steven Maddox] [Entered: 06/25/2024 09:55 AM] (0)
Jun 24, 2024 15 Corrected Entry of Appearance for Steven A. Maddox; Jeremy J. Edwards; Brett Garrison as counsel for Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc. and Amneal Pharmaceuticals LLC. Service: 06/24/2024 by email. [1012927] [24-1936] [Steven Maddox] [Entered: 06/24/2024 02:45 PM] (2)
Jun 24, 2024 14 NOTICE OF NON-COMPLIANCE: The submission of Appellees Amneal Ireland Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC and Amneal Pharmaceuticals, Inc., Entry of Appearance [8], is not in compliance with the rules of this court (see attached). Compliant document due on 07/01/2024. Service as of this date by the Clerk of Court. [1012851] [IMH] [Entered: 06/24/2024 01:12 PM] (2)
Jun 21, 2024 13 Confidential Appellants' Motion for a Stay Pending Appeal filed by Appellants Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd. and Teva Pharmaceuticals USA, Inc. corresponding to Doc. No. [12]. Service: 06/21/2024 by email. [1012678] [24-1936] [William Jay] [Entered: 06/21/2024 07:16 PM] (0)
Jun 21, 2024 12 MOTION of Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc. for an emergency stay pending appeal under Rule 8/18. Service: 06/21/2024 by email. [1012677] [24-1936] [William Jay] [Entered: 06/21/2024 07:03 PM] (64)
Jun 21, 2024 11 Entry of Appearance for Jordan Bock as counsel for Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 06/21/2024 by email. [1012620] [24-1936] [Jordan Bock] [Entered: 06/21/2024 04:18 PM] (1)
Jun 21, 2024 10 Notice of Related Case Information for Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Amneal Ireland Ltd.. Service: 06/21/2024 by email. [1012391] [24-1936] [Steven Maddox] [Entered: 06/21/2024 10:55 AM] (3)
Jun 21, 2024 9 Certificate of Interest for Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Amneal Ireland Ltd.. Service: 06/21/2024 by email. [1012389] [24-1936] [Steven Maddox] [Entered: 06/21/2024 10:54 AM] (4)
Jun 21, 2024 8 Entry of Appearance for Steven A. Maddox; Jeremy J. Edwards; Brett Garrison as counsel for Appellees Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc. and Amneal Ireland Ltd.. Service: 06/21/2024 by email. [1012387] [24-1936] This document is non-compliant. See Doc No.[14] [Steven Maddox] [Entered: 06/21/2024 10:52 AM] (2)
Jun 20, 2024 7 ORDER Any response to the motion [5] is due no later than June 25, 2024, and any reply is due no later than June 27, 2024. Service as of this date by the Clerk of Court. [1012205] [NL] [Entered: 06/20/2024 02:22 PM] (2)
Jun 19, 2024 6 Confidential Motion to Expedite filed by Appellants Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc. and Teva Branded Pharmaceutical Products R&D, Inc. corresponding to Doc. No. [5]. Service: 06/19/2024 by email. [1011968] [24-1936] [William Jay] [Entered: 06/19/2024 09:06 PM] (0)
Jun 19, 2024 5 MOTION of Appellants Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceuticals USA, Inc. to expedite.. Service: 06/19/2024 by email. [1011967] [24-1936] [William Jay] [Entered: 06/19/2024 08:55 PM] (21)
Jun 13, 2024 4 Notice of Related Case Information for Appellants Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 06/13/2024 by email. [1010752] [24-1936] [William Jay] [Entered: 06/13/2024 09:03 AM] (2)
Jun 13, 2024 3 Certificate of Interest for Appellants Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 06/13/2024 by email. [1010750] [24-1936] [William Jay] [Entered: 06/13/2024 09:02 AM] (3)
Jun 13, 2024 2 Entry of Appearance for William M. Jay; Daryl L. Wiesen; Natasha E. Daughtrey; Christopher T. Holding as counsel for Appellants Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. and Norton (Waterford) Ltd.. Service: 06/13/2024 by email. [1010744] [24-1936] [William Jay] [Entered: 06/13/2024 08:59 AM] (2)
Jun 12, 2024 1 Appeal docketed. Received: 06/12/2024. [1010707]Entry of Appearance due 06/26/2024. Certificate of Interest is due on 06/26/2024. Docketing Statement due 06/26/2024. Appellant's brief is due 08/12/2024. [JSP] [Entered: 06/12/2024 04:58 PM] (35)
Menu